Literature DB >> 32166569

Relationship between heart rate response and cardiac innervation in patients with suspected or known coronary artery disease.

Carmela Nappi1, Roberta Assante1, Emilia Zampella1, Valeria Gaudieri1, Giovanni De Simini1, Alessia Giordano1, Adriana D'Antonio1, Wanda Acampa1,2, Mario Petretta3, Alberto Cuocolo4.   

Abstract

BACKGROUND: Chronotropic response to pharmacological stress test is blunted in patients with autonomic neuropathy. The relationship between heart rate (HR) changes during pharmacological stress test and cardiac autonomic dysfunction has not been fully investigated. We assessed the potential interplay between HR response (HRR) and myocardial innervation in patients with suspected or known coronary artery disease (CAD). METHODS AND
RESULTS: We studied 71 patients with suspected or known CAD referred to pharmacological stress myocardial perfusion imaging and 123I metaiodobenzylguanidine (123I-MIBG) cardiac scintigraphy. HRR was calculated as the maximum percent change from baseline according to the formula: (peak HR - rest HR)/rest HR × 100. 123I-MIBG heart-to-mediastinum (H/M) ratio was calculated and a late H/M ratio < 1.6 was considered abnormal. HRR progressively decreased with decreasing late H/M ratio (P for trend = 0.02) and a significant correlation between HRR and late H/M ratio (P = 0.03) was observed. The addition of HRR to a model including age, diabetes, known CAD, left ventricular ejection fraction, and stress-induced ischemia added incremental value in predicting an abnormal late H/M ratio, increasing the global chi-square from 8.09 to 13.8 (P = 0.02).
CONCLUSIONS: The relationship between HRR and cardiac sympathetic innervation in patients with suspected or known CAD confirms a strong interplay between cardiac response to stress tests and cardiac autonomic activation. This finding suggests that HRR may be used as a surrogate for assessing cardiac sympathetic function.
© 2020. American Society of Nuclear Cardiology.

Entities:  

Keywords:  Cardiac innervation; Diagnostic and prognostic application; MPI; Vasodilators

Mesh:

Year:  2020        PMID: 32166569     DOI: 10.1007/s12350-020-02091-7

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  4 in total

1.  Noninvasive delineation of the effects of moderate aging on myocardial perfusion.

Authors:  M J Senneff; E M Geltman; S R Bergmann
Journal:  J Nucl Med       Date:  1991-11       Impact factor: 10.057

2.  Prognostic values of 123I-MIBG myocardial scintigraphy and heart rate variability in patients with heart failure with preserved ejection fraction.

Authors:  Hidenobu Hashimoto; Rine Nakanishi; Sunao Mizumura; Yukiko Hashimoto; Yuriko Okamura; Kyoko Yamanaka; Junichi Yamazaki; Takanori Ikeda
Journal:  J Nucl Cardiol       Date:  2018-11-01       Impact factor: 5.952

Review 3.  Cardiovascular disease in the literature: A selection of recent original research papers.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2018-11-13       Impact factor: 5.952

Review 4.  Cardiac autonomic neuropathy in the diabetic patient: does 123I-MIBG imaging have a role to play in early diagnosis?

Authors:  Lynda A Scott; Peter L Kench
Journal:  J Nucl Med Technol       Date:  2004-06
  4 in total
  2 in total

Review 1.  123I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation.

Authors:  Paola Gargiulo; Wanda Acampa; Gaetano Asile; Vincenza Abbate; Ermanno Nardi; Federica Marzano; Roberta Assante; Carmela Nappi; Antonio Luca Maria Parlati; Christian Basile; Santo Dellegrottaglie; Stefania Paolillo; Alberto Cuocolo; Pasquale Perrone-Filardi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-09-08       Impact factor: 10.057

2.  Prognostic value of heart rate reserve in patients with suspected coronary artery disease undergoing stress myocardial perfusion imaging.

Authors:  Carmela Nappi; Mario Petretta; Roberta Assante; Emilia Zampella; Valeria Gaudieri; Valeria Cantoni; Roberta Green; Fabio Volpe; Leandra Piscopo; Ciro Gabriele Mainolfi; Emanuele Nicolai; Wanda Acampa; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2021-08-03       Impact factor: 3.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.